A novel pre-T cell line derived from acute lymphoblastic leukemia

Area of Science:

• Hematology
• Cell Biology
• Oncology

Background:

• Acute lymphoblastic leukemia (ALL) is a significant hematologic malignancy.
• Establishing reliable cell lines is crucial for understanding leukemia pathogenesis and developing treatments.

Purpose of the Study:

• To establish and characterize a novel human cultured cell line from a patient with acute lymphoblastic leukemia (ALL).
• To define the immunophenotype and cytogenetic profile of the new cell line for research applications.

Main Methods:

• Morphological, cytochemical, and immunological analyses were performed.
• Immunophenotyping included assessments for common-ALL antigen, Ia-like antigen, pan-T cell antigen, B1 antigen, and surface immunoglobulins.
• Cytogenetic analysis was conducted to identify chromosomal abnormalities.

Main Results:

• The P30/Ohkubo cell line demonstrated a pre-T cell phenotype with L2 morphology and localized acid phosphatase staining.
• Key immunological markers such as common-ALL antigen, Ia-like antigen, and pan-T cell antigen were present.
• The cell line exhibited specific chromosomal markers ([11q +, del (9)]) and lacked rosette-forming capacity and B1 antigen.

Conclusions:

• P30/Ohkubo represents a novel, well-characterized cell line of pre-T cell phenotype.
• The stable characteristics of this cell line over 20 months offer a valuable resource for acute lymphoblastic leukemia research.